TNG Pharmaceuticals, Inc. Closes $4.6 Million Series A Financing
2/6/2014 10:39:41 AM
LOUISVILLE, Ky.--(BUSINESS WIRE)--TNG Pharmaceuticals, Inc. (TNG), an animal pharmaceutical company developing an innovative vaccine for cattle to aid in control of the horn fly, announced that it completed a $4.6 million Series A Preferred Stock financing on December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by